Yingke Biopharmaceutical is based in Taizhou, China. It has raised $43M in total funding. Latest round: Series B.
Yingke Biopharmaceutical is based in Taizhou, China. Yingke Biopharmaceutical has raised $43M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2023. The round record for Yingke Biopharmaceutical runs through 2023; nothing later has been disclosed. Investors on record include Beijing Innovation Industry Investment, China Life Private Equity, Sherpa Healthcare Partners, Wuxi Taihu New City Development Group. 4 distinct backers are named across the disclosed rounds.
Every Yingke Biopharmaceutical figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Taizhou at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026